BRIEF — Oncolytics Biotech® Secures Patent Protection To Late 2040S And Provides Intellectual Property Portfolio Update

Oct 12 (Reuters) — Oncolytics Biotech Inc: Oncolytics Biotech® Secures Patent Protection To Late 2040s And Provides Intellectual Property Portfolio Update Oncolytics Biotech - New Method Of Use Patent For Pelareorep Issued In Several Countries; U.s. Issuance Expected Soon Oncolytics Biotech - Company Expects To Add New Composition Of Matter Patent For Next Generation Pelareorep Oncolytics Biotech - Three Patent Applications Pending; One To Be Converted To Track One This Quarter Oncolytics Biotech - New Method Of Use Patents Expected To Provide Protection Into Late 2040s Source text:... Further company coverage: ONCY.O (Reuters.Briefs@thomsonreuters.com;)